WHO ICTRP trial

Real world study on adjuvant treatment of non-small cell lung cancer with…

ChiCTR2100044417 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting

Key facts

Trial ID ChiCTR2100044417
Public title Real world study on adjuvant treatment of non-small cell lung cancer with commonly used anti-cancer traditional Chinese medicine injection
Scientific title Real world study on adjuvant treatment of non-small cell lung cancer with commonly used anti-cancer traditional Chinese medicine injection
Primary sponsor Beijing Hospital of Traditional Chinese Medicined
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Recruiting
Study type Observational study
Phase Retrospective study
Countries China
Conditions NSCLC
Interventions control group:kang'ai injection;Experimental group 1:Kangai injection + Kanglaite Injection;Experimental group 2:Kangai injection + Elemene injection;Experimental group 3:Kangai injection + Xiaoaiping injection;Experimental group 4:Kangai…
Registration date Mar 18, 2021
Target size control group:30;Experimental group 1:30;Experimental group 2:30;Experimental…
Secondary IDs ChiMCTR2100005212
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations